BioCentury
ARTICLE | Management Tracks

Legend’s new look at the top; plus VC moves at Medicxi, OSI and Qiming

November 14, 2020 4:03 AM UTC

Legend Biotech Corp. (NASDAQ:LEGN) appointed Ye “Sally” Wang as chairwoman and promoted Ying Huang to CEO from CFO. Wang, who was already a member of Legend’s board, is president, COO and a director of GenScript Biotech Corp. (HKEX:1548), Legend’s majority shareholder and former parent company. Huang has been serving as interim CEO since September, when Legend’s Frank Zhang, who had been chairman and CEO, was placed under “residential surveillance” as part of an investigation into GenScript. Huang will remain CFO until a successor is identified.

Jon Edwards has left Medicxi to join Red Tree Venture Capital as managing director. Heath Lukatch and Jennifer Cochran founded the firm, which focuses on therapeutics and medical devices...